Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2012
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149695 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149672 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
06/14/2012US20120149659 Compositions and methods for delivering an agent to a wound
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120149632 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120148683 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
06/14/2012US20120148678 Sustained release of poorly water soluble active compounds
06/14/2012US20120148676 Artificial cell constructs for cellular manipulation
06/14/2012US20120148666 Anti-rsv immunogens and methods of immunization
06/14/2012US20120148663 Lipophilic drug carrier
06/14/2012US20120148660 Conjugates of synthetic tlr agonists and uses therefor
06/14/2012US20120148655 Multi-layered gradient vaginal ring
06/14/2012US20120148646 Radio-opaque bioactive glass materials
06/14/2012US20120148635 Gallium formulation for the treatment and prevention of infectious diseases
06/14/2012US20120148633 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148623 Vaccination for lawsonia intracellularis
06/14/2012US20120148622 Live Attenuated Influenza Virus Vaccines Comprising Microrna Response Elements
06/14/2012US20120148621 Methods and compositions for promoting a cell-mediated immune response
06/14/2012US20120148620 Compositions and methods for vaccinating cattle
06/14/2012US20120148619 Adjuvanting meningococcal factor h binding protein
06/14/2012US20120148618 Multiple variants of meningococcal protein nmb1870
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148614 Interaction of Moraxella Catarrhalis with Epithelial Cells, Extracellular Matrix Proteins and the Complement System
06/14/2012US20120148601 Bacterial superantigen vaccines
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies
06/14/2012US20120148577 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
06/14/2012US20120148570 Methods and compositions for treating respiratory disease-challenged animals
06/14/2012US20120148569 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
06/14/2012US20120148534 Methods and compositions of treating a flaviviridae family viral infection
06/14/2012US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148522 Biocompatible Polyelectrolyte Complexes and Methods of Use
06/14/2012US20120148520 Organic Iodine Complex Durable Barrier With Antimicrobial Preparations
06/14/2012US20120148519 Ophthalmic lens
06/14/2012US20120148516 Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
06/14/2012US20120148507 Composition for preventing infection of new influenza a (h1n1) virus comprising ginkgo extract, air filter comprising the same, and air cleaning device comprising the filter
06/14/2012US20120148506 Antiseptic pharmaceutical composition for oral hygiene and the treatment of oral diseases of microbial origin
06/14/2012US20120148505 Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
06/14/2012US20120148503 Non-flammable insecticide composition and uses thereof
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012CA2823837A1 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
06/14/2012CA2820642A1 Galectin-9-secreting cell, and production method and use of the same
06/14/2012CA2820435A1 Glycomimetic compounds as anti-infectious against pathogens lectins
06/14/2012CA2820394A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012CA2820393A1 Process for the manufacture of ajoene derivatives
06/14/2012CA2820065A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/14/2012CA2819824A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012CA2819548A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
06/14/2012CA2819366A1 Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
06/14/2012CA2818012A1 Oligosaccharide composition for treating acute respiratory tract infections
06/13/2012EP2463293A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
06/13/2012EP2462991A1 Composition and use of a fermented olive leaf product for the treatment of nail infections
06/13/2012EP2462940A1 Stabilized bacteriophage formulations
06/13/2012EP2462138A1 Antiviral compounds and methods of making and using there of cross reference to related applications
06/13/2012EP2462136A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors
06/13/2012EP2462135A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors
06/13/2012EP2462122A1 Novel viral replication inhibitors
06/13/2012EP2461826A2 Composition for treating hbv infection
06/13/2012EP2461822A2 Polymer particles and uses thereof
06/13/2012EP2461811A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
06/13/2012EP2307435B1 Salts of hiv inhibitor compounds
06/13/2012EP1626051B1 Crystals of quinolinecarboxylic acid derivative solvate
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012EP1613273B1 Recombinant il-9 antibodies and uses thereof
06/13/2012EP1478438B1 Methods and compositions for the treatment of asthma
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0821690B1 Nucleotide analogues for the treatment of viral infections
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof
06/13/2012CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella
06/13/2012CN102498118A Inhibitors of flaviviridae viruses
06/13/2012CN102498100A Heterocyclic antiviral compounds
06/13/2012CN102497872A Inhibitor of inflammatory conditions
06/13/2012CN102497869A Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
06/13/2012CN102497868A Mixture of non-digestible oligosaccharides for stimulating the immune system
06/13/2012CN102497866A Oxazolidinone containing dimer compounds, compositions and methods to make and use
06/13/2012CN102497860A Treatment of viral infections
06/13/2012CN102497853A Dry powder formulations and methods for treating pulmonary diseases
06/13/2012CN102492661A Preparation method and application of immunization preparation for controlling novel duck reovirus
06/13/2012CN102492629A Marine fungi penicillium thomii, extract and application thereof
06/13/2012CN102492038A Anti-human Tim-3 neutralized monoclonal antibody L3D and application thereof
06/13/2012CN102492034A Rice field eel serum transferrin, preparation method and use thereof
06/13/2012CN102492011A Method for preparing antibacterial compound from scorpion
06/13/2012CN102491979A 1-hydroxyethyl-5-substituted indolone derivative and preparation method and application thereof
06/13/2012CN102491978A Method for preparing natural pigments, polysaccharide and saponin by utilizing disused asparagus resources
06/13/2012CN102491933A Substituted 5-acrylic acid indole dione derivative, as well as preparation method and application thereof
06/13/2012CN102491932A 3-indoline ketone derivative, and preparation method and application thereof
06/13/2012CN102488908A Flushing fluid for electrocision and application of same
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 1798